THE CLINICAL APPLICATION OF CRRT—CURRENT STATUS: Vascular Access for Continuous Renal Replacement Therapy
- 1 March 2009
- journal article
- review article
- Published by Wiley in Seminars in Dialysis
- Vol. 22 (2) , 133-136
Abstract
A working vascular access is essential for performing continuous renal replacement therapy (CRRT) efficiently and without interruption. Dual-lumen temporary hemodialysis catheters are the catheters of choice, although tunneled catheters can also be utilized if therapy is expected to be prolonged. Hemodialysis catheters have to be inserted under ultrasound guidance by trained personnel, using aseptic conditions. The right internal jugular vein is the preferred site. Catheter malfunction and catheter-related infections can be reduced by adhering to preventive guidelines such as ultrasound guidance for placement, strict hand hygiene, gauze dressings, and sterile techniques during catheter handling. Antibiotic or antiseptic-coated catheters and lock solutions may be beneficial in certain patients, but these are not widely used due to the concern for resistant organisms and allergic reactions.Keywords
This publication has 12 references indexed in Scilit:
- Femoral vs Jugular Venous Catheterization and Risk of Nosocomial Events in Adults Requiring Acute Renal Replacement TherapyJAMA, 2008
- Femoral Localization and Higher Ultrafiltration Rate but Not Concentration of Heparin Used for Canal Locking of Hemodialysis Catheter Are Negative Predictors for Its MalfunctionAmerican Journal of Nephrology, 2007
- Current Management of Vascular AccessClinical Journal of the American Society of Nephrology, 2007
- Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patientsCritical Care, 2006
- Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: A prospective, randomized clinical trialKidney International, 2006
- Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis PatientsJournal of the American Society of Nephrology, 2005
- Vascular access for dialysis in the intensive care unitBest Practice & Research Clinical Anaesthesiology, 2004
- Alteplase Versus Urokinase for Occluded Hemodialysis CathetersAnnals of Pharmacotherapy, 2003
- Efficacy of tissue plasminogen activator administration on patency of hemodialysis access cathetersAmerican Journal of Kidney Diseases, 2000
- Ultrasound guidance for placement of central venous cathetersCritical Care Medicine, 1996